Get a weekly digest of the latest psychedelic research, new studies, and platform updates delivered to your inbox.
No spam, ever. Unsubscribe anytime.
Substance Profile
AL-LAD (6-allyl-6-nor-LSD) is a semi-synthetic ergoline and LSD analog developed by Andrew Shulgin as part of his research into LSD derivatives. It produces a qualitatively similar but shorter and more visually pronounced experience compared to LSD. Duration is 6-8 hours versus 8-12 for LSD. AL-LAD is often described as a more manageable psychedelic with fewer thought loops and less anxiety tendency.
No subjective effects data available yet.
No linked studies yet.